Veterinary Medicines

KOLIERYSIN NEO, Injekční emulze

Authorised
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
Download as PDF

Product identification

Medicine name:
KOLIERYSIN NEO, Injekční emulze
Active substance:
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
Target species:
  • Pig (pregnant sow)
  • Pig (sow, nullipar)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (pregnant sow)
      • Meat and offal
        0
        day
    • Pig (sow, nullipar)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/077/04-C
Date of authorisation status change: